Skip to content
  • Sunday, 26 July 2026
  • 4:37 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Researchers Identify Experimental Strategy to Boost MeCP2 Protein Levels as Potential Therapy for Rett Syndrome
Neuroscience & Brain Research

Researchers Identify Experimental Strategy to Boost MeCP2 Protein Levels as Potential Therapy for Rett Syndrome

Rifan Muazin Mar 21, 2026 0

A collaborative research team at the Texas Children’s Duncan Neurological Research Institute (NRI) and Baylor College of Medicine has unveiled…

Read More
Pharmaceutical R&D

UK Government Overhauls Medicine Regulation to Accelerate Patient Access and Boost Life Sciences Sector

Teuku Ryan Mar 19, 2026 0

The United Kingdom is set to revolutionize its medicine regulation framework, a move poised to significantly expedite patient access to…

Read More

Posts pagination

1 2
Digital PCR: Tracing the Evolution and Impact of a Transformative Life Science TechnologyScientists May Have Found What Really Triggers Alzheimer’s DiseaseMixing evidence and imagination brings three real ancient Romans to lifeGlobal Regulatory Shift Accelerates Adoption of New Approach Methodologies in Preclinical Safety Studies
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ